Renalytix AI lands $29 mln
UK-based Renalytix AI plc, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, has secured $29 million in funding. The investors were not named.
15 November 2018•1 min read
UK-based Renalytix AI plc, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, has secured $29 million in funding. The investors were not named.
